Yayın:
Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; Three cases

Basit Görünüm
dc.contributor.buuauthorAkkaya, Cengiz
dc.contributor.buuauthorKaya, Berrin Yalınbaş
dc.contributor.buuauthorKotan, Zenep
dc.contributor.buuauthorSarandol, Aslı
dc.contributor.buuauthorErsoy, Canan
dc.contributor.buuauthorKirli, Selçuk
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPsikiyatri Ana Bilim Dalı
dc.contributor.researcheridAAH-8861-2021
dc.contributor.scopusid14061855100
dc.contributor.scopusid57213735495
dc.contributor.scopusid15044759000
dc.contributor.scopusid14020405100
dc.contributor.scopusid6701485882
dc.contributor.scopusid14019745700
dc.date.accessioned2022-01-11T07:36:05Z
dc.date.available2022-01-11T07:36:05Z
dc.date.issued2009-08
dc.description.abstractSchizophrenia is a chronic and debilitating psychotic mental disorder that affects about 1% of the world's population. Antipsychotic drugs are the mainstay of treatment in schizophrenia. Hyperprolactinemia, which is a common side effect of typical antipsychotics, is also associated with the use of some of the newer atypical agents. Antipsychotics may enhance prolactinoma growth as manifested by an increase in serum prolactin concentration. Prolactin-secreting pituitary adenomas possibly related with antipsychotics have been described in the literature. To our knowledge, this is the first series of cases showing a possible relation between pituitary adenomas and amisulpride treatment in patients with schizophrenia.
dc.identifier.citationAkkaya, C. vd. (2009). "Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; Three cases". Journal of Psychopharmacology, 23(6), 723-726.
dc.identifier.doi10.1177/0269881108091252
dc.identifier.endpage726
dc.identifier.issn0269-8811
dc.identifier.issue6
dc.identifier.pubmed18562408
dc.identifier.scopus2-s2.0-67651151346
dc.identifier.startpage723
dc.identifier.urihttps://doi.org/10.1177/0269881108091252
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/0269881108091252
dc.identifier.urihttp://hdl.handle.net/11452/23989
dc.identifier.volume23
dc.identifier.wos000268187400017
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSage Publications
dc.relation.journalJournal of Psychopharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAmisulpride
dc.subjectHyperprolactinemia
dc.subjectPituitary adenoma
dc.subjectSecreting pituitary-adenoma
dc.subjectGrowth
dc.subjectSchizophrenia
dc.subjectThioridazine
dc.subjectNeuroleptics
dc.subjectRisperidone
dc.subjectMedication
dc.subjectDisorder
dc.subjectWoman
dc.subjectNeurosciences & neurology
dc.subjectPharmacology & pharmacy
dc.subjectPsychiatry
dc.subject.emtreeAlprazolam
dc.subject.emtreeAmisulpride
dc.subject.emtreeAripiprazole
dc.subject.emtreeBiperiden
dc.subject.emtreeFluvoxamine
dc.subject.emtreeHaloperidol
dc.subject.emtreeOlanzapine
dc.subject.emtreeProlactin
dc.subject.emtreeQuetiapine
dc.subject.emtreeRisperidone
dc.subject.emtreeThioridazine
dc.subject.emtreeValproic acid
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeCase report
dc.subject.emtreeDiagnostic and statistical manual of mental disorders
dc.subject.emtreeDrug dose increase
dc.subject.emtreeDrug dose reduction
dc.subject.emtreeDrug substitution
dc.subject.emtreeDrug withdrawal
dc.subject.emtreeExtrapyramidal symptom
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeHyperprolactinemia
dc.subject.emtreeHypophysis adenoma
dc.subject.emtreeMale
dc.subject.emtreeMicroadenoma
dc.subject.emtreeNuclear magnetic resonance
dc.subject.emtreeNuclear magnetic resonance imaging
dc.subject.emtreePriority journal
dc.subject.emtreeProlactin blood level
dc.subject.emtreeProlactinoma
dc.subject.emtreeSchizophrenia
dc.subject.meshAdult
dc.subject.meshAntipsychotic agents
dc.subject.meshBrain
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshHyperprolactinemia
dc.subject.meshMagnetic resonance imaging
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshPituitary neoplasms
dc.subject.meshProlactin
dc.subject.meshProlactinoma
dc.subject.meshPsychiatric status rating scales
dc.subject.meshSchizophrenia
dc.subject.meshSchizophrenic psychology
dc.subject.meshSulpiride
dc.subject.scopusHyperprolactinemia; Prolactin; Aripiprazole
dc.subject.wosClinical neurology
dc.subject.wosNeurosciences
dc.subject.wosPharmacology & pharmacy
dc.subject.wosPsychiatry
dc.titleHyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; Three cases
dc.typeArticle
dc.wos.quartileQ1
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Psikiyatri Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications